Bright Uro

Bright Uro, founded in 2019 and based in San Francisco, is a commercial-stage medical device company in the urology sector. Its flagship product, the Glean UDS, is an FDA-cleared, non-invasive, wireless monitoring system that represents a significant departure from traditional, catheter-based urodynamic testing. The company targets a large market of approximately 80 million US adults with lower urinary tract symptoms, aiming to expand patient access, improve diagnostic reliability, and enhance the overall patient and clinician experience. Bright Uro is positioned as a private, revenue-generating company with a clear focus on commercializing its innovative device.

Wireless, catheter-free urodynamic monitoring system with cloud-based data synchronization and analytics.

Bright Uro competes against established manufacturers of traditional, catheter-based urodynamic systems (e.g., Laborie, Medtronic). Its primary competitive advantage is the elimination of catheters. It may also face future competition from other startups developing non-invasive monitoring technologies for bladder function.